Skip to content
MarketScale
‹ Back to IndustriesSciences

James Webb Telescope Observations Heat up with Coldest Ice Detection

The harshest arctic winters have got nothing on the chill from deep space. The James Webb Space Telescope (JWST) continues to provide gifts for scientists and space enthusiasts with its latest discovery: ice found within the deepest reaches of an interstellar molecular cloud. As reported in the journal Nature Astronomy, the JWST measured the frozen…

This story was produced through MarketScale. See how Sciences teams put it to work with Executive Thought Leadership.

By Sciences · Interstellar StudiesJames Webb TelescopeJwstSpace Exploration
Share

Key takeaways

01

The harshest arctic winters have got nothing on the chill from deep space.

02

The James Webb Space Telescope (JWST) continues to provide gifts for scientists and space enthusiasts with its latest discovery: ice found within the deepest reaches of an interstellar molecular cloud.

03

As reported in the journal Nature Astronomy, the JWST measured the frozen…

Get featured

Want to get featured in MarketScale Sciences?

Create a free MarketScale workspace and get your company's expertise featured across our Sciences coverage. No credit card, no demo required.

Request an invite

The harshest arctic winters have got nothing on the chill from deep space. The James Webb Space Telescope (JWST) continues to provide gifts for scientists and space enthusiasts with its latest discovery: ice found within the deepest reaches of an interstellar molecular cloud. As reported in the journal Nature Astronomy, the JWST measured the frozen molecules at minus 440 degrees Fahrenheit (minus 263 degrees Celsius).

Could this discovery provide clues to early planet formation and possible early lifeforms?

“These observations open a new window on the formation pathways for the simple and complex molecules that are needed to make the building blocks of life,” lead study author Melissa McClure, an astronomer at Leiden Observatory in the Netherlands, said.

How is the rest of the scientific community responding to this life-altering (literally) news? Jason Steffen, Assistant Professor of Physics and Astronomy at the University of Nevada, Las Vegas, and member of NASA’s Kepler mission science team since 2008, gave some context around this latest JWST observation and why other astronomers and space professionals are eager to learn even more about these icy molecules.

In related efforts, the University of Nevada, Las Vegas research team discovered a new form of ice that redefines the properties of water at high pressures. This type of high-pressure water may be present in the interior of distant planets under immense strain from the forces of gravity. Perhaps this is the next bucket list item for the JWST to discover as it continues to probe the unknown reaches of space.

Jason’s Thoughts

“New results from the James Webspace Telescope Show it has the power to do exactly what it was designed to do. That is to peer through layers of cold gas and dust to see what is going on behind them. These layers would be opaque to visible light and hide the goings-on deep inside the coldest and dirtiest places in the universe.

In this study, astronomers use the James Webspace Telescope to study the composition of condensed material deep within the cold cloud of gas called Chameleon I. This is a cloud where stars are forming. They wanted to see how different ices or molecules of light elements condensed out of that cloud. These light elements include carbon, oxygen, nitrogen, hydrogen, and sulfur, and these elements are important for the formation of planets as well as the development of planetary atmospheres and eventually life on any of these planets that might form as infrared light from distant stars pass through that cloud.

It will be absorbed by these different ices, and we can measure what they’re made out of within that. These results will help us piece together the development of planet-forming material from within this cloud. And it’s especially important because this is before the time that most of the stars have formed and certainly before the time that any of the planets have formed.”

Article by James Kent.

Your experts belong here

Every story in MarketScale Sciences starts with a company putting its lab directors, applications scientists, and field specialists on the record. Buyers are already reading this topic. The only question is whose experts they find.

Lab and research buyers verify before they trial, and your scientists give them something credible to verify against.

Get your team featuredSee how it works15 minutes, straight to a calendar.

About the author

S
Sciences

Follow Sciences Insights

Get new expert content in your inbox.

Sciences: are you visible to AI?

Before they reach out, Sciences buyers ask AI engines which vendors to trust. See how AI describes your company today, and where competitors show up instead.

Free workspace

You just read one Sciences expert. Your company is full of them.

This article was produced through MarketScale. The same platform turns your lab directors, applications scientists, and field specialists into the articles, video, and social content Sciences buyers are searching for. Create a free workspace and see it with your own people. No credit card, no demo required.

NPS +73 · 1,000+ creators · 38+ countries

What you get, free

Your own MarketScale Studio workspace
One video edit a month, on us
AI writing, editing, and publishing tools
In-platform coaching to learn the system

More Sciences Insights

Genentech’s $750M Hillsboro build adds device fill-finish capacity by 2031

Genentech’s $750M Hillsboro build adds device fill-finish capacity by 2031

Genentech is investing $750 million in a new fill-finish plant in Hillsboro. The facility will focus on the production of prefilled syringes and autoinjectors. The site is expected to become operational in 2031.

  • 01Genentech is investing $750 million in a new Hillsboro facility.
  • 02The facility will produce prefilled syringes and autoinjectors.
  • 03Operations at the plant are expected to begin in 2031.

Aug 27, 2026

4basebio hpDNA in Genezen projects could cut AAV input DNA by 30%

4basebio hpDNA in Genezen projects could cut AAV input DNA by 30%

4basebio's cell-free hpDNA will be used by Genezen as starting material for viral vectors, potentially reducing the need for AAV input DNA by 30%. This innovation may lead to changes in the specification of plasmids and project timelines in gene therapy programs.

  • 01Genezen will utilize 4basebio’s cell-free hpDNA for viral vector production.
  • 02This approach could reduce AAV input DNA requirements by 30%.
  • 03The adoption of hpDNA could lead to changes in plasmid specification and project timelines.

Aug 27, 2026

Bristol Myers exits Cellares deal, putting standardized cell therapy capacity in doubt

Bristol Myers exits Cellares deal, putting standardized cell therapy capacity in doubt

Bristol Myers has terminated its agreement with Cellares, which raises concerns about the standardized capacity for cell therapy production. This decision highlights the importance of aligning manufacturing processes with production capabilities, rather than merely focusing on the availability of factory slots.

  • 01Bristol Myers has terminated its agreement with Cellares, affecting cell therapy capacity.
  • 02Aligning process fit with production capabilities is crucial for cell therapy success.
  • 03Factory slots alone are not sufficient to ensure supply plans in cell therapy production.

Aug 26, 2026

Explore More Sciences Insights

Read more expert perspectives from across Sciences.

Browse Sciences Hub

About the Expert

S
Sciences

For B2B teams

Your experts could be publishing here

Stories like this one run on content MarketScale captures from real practitioners. See how your team's expertise becomes coverage in Sciences and beyond.

Book a 15-minute demo

Or call us. No forms required. We pick up. 214-945-2512